期刊文献+

血浆循环DNA水平与血常规指标的关联分析 被引量:2

Correlation Analysis Between Plasma Circulating DNA and Routine Blood Parameters
下载PDF
导出
摘要 目的:通过观察血浆循环DNA(cfDNA)浓度与血常规指标间的关系,探索cfDNA的来源。方法:用实时荧光定量PCR测定选定人群的血浆cfDNA浓度,用ADVIA120血细胞分析仪测定血常规指标,用双变量关联分析和逻辑回归分析血浆cfDNA浓度与性别、年龄及血常规指标间的相关性。结果:男性的血浆cfDNA浓度(23.23±3.186)略高于女性(18.55±2.037),但差异无显著性(P=0.2183);在各年龄段中,61-70岁年龄段的cfDNA浓度(23.20±4.274)最高,其次为70岁以上年龄段(20.92±2.089),51-60岁年龄段最低(15.81±1.747),但三者之间的差异没有显著性(P=0.3276);双变量关联分析表明血浆cfDNA浓度与过氧化物酶活性指数、血红蛋白及红细胞比积呈正相关(P〈0.05),与性别、年龄及其他血常规指标无关;逻辑回归分析提示血浆cfDNA浓度升高只与平均血小板浓度和过氧化物酶活性指数呈正相关(P〈0.05)。结论:血浆cfDNA增加可能与平均血小板浓度升高及过氧化物酶含量或活性有关,血小板前体细胞(即巨核细胞)可能是cfDNA的一个重要来源。 Objective: To investigate the origin of circulating DNA(efDNA) through observing the correlation between plasma cfDNA level and the routine blood parameters. Methods: Determination of the plasma cfDNA level from the selected population was performed by using real-time fluorescent quantitative PCR, routine blood parameters were evaluated with ADVIA120 blood cell analyzer, and the bivariate correlation and logistic regression were run using SPSS16.0. Results: The mean plasma cfDNA level in the male group(23.23±3.186) was slightly higher than that in the female group(18.55±2.037)(P=0.2183). The highest mean plasma cfDNA level(23.20±4.274) was observed in the 61-70 years old interval, then in the above 70 years old interval(20.92±2.089), and the lowest mean plasma cfDNA(15.81±1.747) ence among the three subgroup is was present in the subjects aged between not significant(P=0.3276). The results of 51-60 years old. However, the differbivariate correlation analysis indicated that plasma cfDNA level was positive correlated with peroxidase activity index, hemoglobin content, and hematocrit (P〈0.05), and was without association with gender, age and the other routine blood parameters. The results of logistic regression analysis showed that the plasma cfDNA level was positive associated with only two routine blood parameters, mean platelet concentration and peroxidase activity index(P〈0.05). Conclusion: Increase of plasma cfDNA may be correlated with elevated platelet concentration, as well as the peroxidase content or activity. The precursor cell of platelet(megakaryocyte) may be a important resource of plasma cfDNA.
出处 《生物技术通讯》 CAS 2012年第4期577-580,共4页 Letters in Biotechnology
基金 国家自然科学基金(81100244/H2501) 广东省优秀博士论文作者资助项目(sybzzxm201127) 广州医学院博士启动基金(303005002-0361)
关键词 循环DNA 血小板 过氧化物酶活性指数 circulating DNA platelet peroxidase activity index
  • 相关文献

参考文献10

  • 1Lui Y Y, Dennis Y M. Circulating DNA in plasma and serum: biology, preanalytical issues and diagnostic applications [J]. Clin Chem Lab Med, 2002,40(10):962-968.
  • 2Wagner J. Free DNA-new potential analyte in clinical laboratory diagnostics[J] Biochem Med(Zagreb), 2012,22(1):24-38.
  • 3Scalzo P L, Ikuta N, Cardoso F, et al. Quantitative plasma DNA analysis in Parkinson's disease[J]. Neurosci Lett, 2009, 452(1):5-7.
  • 4van der Vaart M, Pretorius P J. Circulating DNA. Its origin and fluctuation[J]. Ann N Y Acad Sci, 2008,1137:18-26.
  • 5Tamagawa-Mineoka R, Katoh N, Kishimoto S. Platelets play important roles in the late phase of the immediate hypersensi- tivity reaction[J]. J Allergy Clin Immunol, 2009,123(3):581- 587.
  • 6Wang S H, Liang C J, Weng Y W, et al. Ganoderma lucidum polysaccharides prevent platelet-derived growth fac- tor-stimulated smooth muscle cell proliferation in vitro and neointimal hyperplasia in the endothelial-denuded artery in vivo[J]. J Cell Physiol, 2012,227(8):3063-3071.
  • 7Tushuizen M E, Diamant M, Sturk A, et al. Cell-derived microparticles in the pathogenesis of cardiovascular disease: friend or foe[J] Arterioscler Thromb Vasc Biol, 2011,31(1):4- 9.
  • 8Buergy D, Wenz F, Groden C, et al. Tumor-platelet interaction in solid tumors[J]. Int J Cancer, 2012,130(12):2747-2760.
  • 9夏文颖,丁清清,潘世扬,束永前,徐婷,陆雅春,耿雁,陈丹,黄珮珺,黄蕾,徐建.血浆DNA定量检测在晚期肺癌患者个体化治疗中的应用[J].临床检验杂志,2010,28(3):185-187. 被引量:5
  • 10Bluteau D, Lordier L, Di Stefano A, et al. Regulation of megakaryocyte maturation and platelet formation[J]. J Thromb Haemost, 2009,7(Suppl 1):227-234.

二级参考文献13

  • 1陈丹,潘世扬,张丽霞,高丽,谢而付,黄?,戎国栋.人血浆DNA双重实时荧光定量PCR检测法的建立[J].临床检验杂志,2007,25(3):177-179. 被引量:19
  • 2Pathak AK, Bhutani M, Kumar S, et al. Circulating cell-free DNA in plasma/serum of lung cancer patients as a potential screening and prognostic tool[J]. Clin Chem, 2006, 52 (10) :1833-1842.
  • 3Holdenrieder S, Stieber P, von Pawel J, et al. Circulating nueleosomes predict the response to chemotherapy in patients with advanced non-small cell lung cancer[ J]. Clin Cancer Res, 2004, 10 ( 18 Pt 1 ) : 5981-5987.
  • 4Trejo-BecelTil C, Ofiate-Ocafia LF, Taja-Chayeb L, et al. Sermn nucleosomes during neoadjuvant chemotherapy in patients with cervical cancer. Predictive and prognostic significance [ J ]. BMC Cancer, 2005, 5: 65.
  • 5Gautschi O, Bigosch C, Huegli B, et al. Circulating deoxyribonucleic acid as prognostic marker in non-small-cell lung cancer patients undergoing chemotherapy [ J ]. J Clin Oncol, 2004, 22 (20) : 4157- 4164.
  • 6Sozzi G, Conte D, Mariani L, et al. Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of hmg cancer patients[J]. Cancer Res, 2001 , 61 (12) : 4675-4678.
  • 7Rosell R, Cecere F, Santarpia M, et al. Predicting the outcome of chemotherapy for lung cancer [J]. Curr Opin Pharmacol, 2006,6 (4) :323-351.
  • 8Pan S, Zhang L, Gao L, et al. The property of methylated APC gene promoter and its influence on lung cancer cell line[ Jl. Biomed Pharmacother, 2009, 63(7): 463-468.
  • 9Brock MV, Hooker CM, Ota-Machida E, et al. DNA methylation markers and early recurrence in stage I lung cancer[J]. N Engl J Med, 2008, 358(11) :1118-1128.
  • 10Fleischhacker M, Schmidt B. Circulating nucleic acids (CNAs) and cancer - a survey[J]. Biochim Biophys Acta, 2007, 1775( 1 ) :181- 232.

共引文献4

同被引文献18

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部